Acceptability of Antiretroviral Pre-exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities
Emtricitabine/tenofovir disoproxil fumarate as pre-exposure prophylaxis (PrEP) can prevent HIV infection among at-risk individuals, including young transgender women (YTW). We used baseline data from 230 HIV-uninfected YTW (ages 16–29 years) who were enrolled in Project LifeSkills during 2012–2015....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer New York LLC
2018
|
Subjects: | |
Online Access: | View Fulltext in Publisher |